---
figid: PMC4695870__cancers-07-00870-g002
figtitle: Melanoma cells develop resistance to MAPK inhibitors by mutating (mut) or
  altering expression of a number of proteins which reactivate MAPK signaling and/or
  activate alternative survival pathways such as the PI3K pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4695870
filename: cancers-07-00870-g002.jpg
figlink: /pmc/articles/PMC4695870/figure/cancers-07-00870-f002/
number: F2
caption: Melanoma cells develop resistance to MAPK inhibitors by mutating (mut) or
  altering expression of a number of proteins which reactivate MAPK signaling and/or
  activate alternative survival pathways such as the PI3K pathway. Some alterations
  known to drive resistance are shown in blue. Targeting epigenetic regulators may
  be able to overcome these resistance mechanisms by targeting the resistance mechanism
  directly or downstream signaling.
papertitle: Histone Modifications, Modifiers and Readers in Melanoma Resistance to
  Targeted and Immune Therapy.
reftext: Stuart J Gallagher, et al. Cancers (Basel). 2015 Dec;7(4):1959-1982.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9201181
figid_alias: PMC4695870__F2
figtype: Figure
redirect_from: /figures/PMC4695870__F2
ndex: 5a6f96e2-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4695870__cancers-07-00870-g002.html
  '@type': Dataset
  description: Melanoma cells develop resistance to MAPK inhibitors by mutating (mut)
    or altering expression of a number of proteins which reactivate MAPK signaling
    and/or activate alternative survival pathways such as the PI3K pathway. Some alterations
    known to drive resistance are shown in blue. Targeting epigenetic regulators may
    be able to overcome these resistance mechanisms by targeting the resistance mechanism
    directly or downstream signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - ERRFI1
  - KDM4A
  - FOXD3
  - NRAS
  - NF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BRAF
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - DNER
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - BPTF
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - EZH2
  - EGFR
  - AXL
  - PDGFRB
  - PDGFRA
  - MET
  - HGF
  - IL6
  - SOS1
  - NRG1
  - Cancer
  - Lung cancer
---
